Helus Pharma Appoints Michael Halstead CEO, Effective Immediately
(RTTNews) - On Monday, Cybin D/B/A Helus Pharma (HELP) announced that it has appointed Michael Halstead as Chief Executive Officer, effective immediately.
Halstead brings 25 years of industry experience, most recently serving as President of Intra-Cellular Therapies, Inc. (ITCI).
Before Intra-Cellular, Halstead was a senior leader at Warner Chilcott plc.
In the pre-market activity on the Nasdaq, the shares were trading 0.90 percent lower at $7.75, after closing Friday's closing 3.93 percent down
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.